focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORPH.L Regulatory News (ORPH)

  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Open Orphan PLC

13 Dec 2019 11:44

RNS Number : 8448W
SpreadEx Limited
13 December 2019
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Michael Hennigan

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Open Orphan PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

12/12/2019

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

ORD GBP 0.001

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

2,301,429

0.90

(2) Cash-settled derivatives:

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

TOTAL:

2,301,429

0.90

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

ORD GBP 0.001

ORD GBP 0.001

ORD GBP 0.001

Sale

Sale

Sale

250,000

250,000

100,000

GBP 0.0525

GBP 0.0525

GBP 0.0526

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

none

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

none

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

13/12/2019

Contact name:

David Corben

Telephone number:

01727895135

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETGGGBGPUPBGGW
Date   Source Headline
12th Dec 20194:41 pmRNSForm 8.3 - Open Orphan PLC
11th Dec 20194:03 pmRNSForm 8.3 - Open Orphan
11th Dec 201911:55 amRNSForm 8.5 (EPT/NON-RI)
11th Dec 201911:13 amGNWForm 8.3 - Open Orphan
11th Dec 20197:00 amRNSForm 8 (OPD)
10th Dec 20194:43 pmRNSForm 8 (DD) Open Orphan plc
10th Dec 201911:55 amRNSForm 8.5 (EPT/NON-RI)
10th Dec 20199:59 amPRNForm 8.3 - Open Orphan
10th Dec 20197:00 amRNSRule 2.9 Announcement
9th Dec 20191:27 pmRNSTotal Voting Rights
9th Dec 201912:21 pmPRNForm 8.3 - Open Orphan Plc
9th Dec 20197:00 amRNSRecommended All-Equity Offer
25th Nov 20197:00 amRNSEarly adopters signed for Genomic Health DataBANK
18th Nov 20197:00 amRNSContract signed with Carna Bioscience
15th Nov 20197:00 amRNSJefferies 2019 London Healthcare Conference
11th Nov 20197:00 amRNSPreferred Partner Agreement
24th Oct 20197:00 amRNSValue the Markets Webinar
21st Oct 20197:00 amRNSInvestor Event Attendance and Presentation
15th Oct 20197:00 amRNSAgreement signed with Empiric Logic
8th Oct 20197:00 amRNSInvestor Event Attendance and Presentation
2nd Oct 20193:58 pmRNSResult of AGM
1st Oct 201911:08 amRNSHolding(s) in Company
27th Sep 20198:00 amRNSEuronext Growth Dublin Notice
25th Sep 20197:00 amRNSInterim Results for 6 months ended 30 June 2019
23rd Sep 20193:39 pmRNSExercise of Warrants and Issue of Shares
16th Sep 20197:00 amRNSInvestor Event Attendance and Presentation
12th Sep 20197:00 amRNSNotice of AGM
10th Sep 20197:00 amRNSInvestor Event Attendance and Presentation
9th Sep 20197:00 amRNSInvestor Event Attendance and Presentation
3rd Sep 20197:00 amRNSInvestor Event Attendance and Presentation
2nd Sep 20197:00 amRNSUpcoming Investor Events
1st Aug 20197:00 amRNSDirectorate Changes
30th Jul 20198:00 amRNSEuronext Growth Dublin Notice
25th Jul 20197:00 amRNSExercise of Warrants and Issue of Shares
12th Jul 20197:00 amRNSChange to interests of a significant shareholder
12th Jul 20197:00 amRNSIntegumen Shares
9th Jul 20195:26 pmRNSHolding(s) in Company
28th Jun 20198:00 amRNSEuronext Growth Dublin Notice
28th Jun 20197:59 amRNSEuronext Growth Dublin Cancellation Notice
28th Jun 20197:00 amRNSFirst Day of Dealings and Re-admission
25th Jun 20191:24 pmRNSDirectorate Update
14th Jun 201912:13 pmRNSEuronext Growth - Schedule One
14th Jun 201911:00 amRNSSchedule One - Ven Life Sciences Holdings plc
11th Jun 20197:30 amRNSEuronext Growth Dublin Market Restoration Notice
11th Jun 20197:30 amRNSRestoration - Venn Life Sciences Holding Plc
11th Jun 20197:01 amRNSPlacing of Shares
11th Jun 20197:00 amRNSAudited Final Results
10th May 20197:30 amRNSEuronext Growth Dublin Suspension Notice
10th May 20197:30 amRNSSuspension - Venn Life Sciences Holdings Plc
10th May 20197:01 amRNSConditional Acquisition of Open Orphan DAC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.